Brittany Valdez Nava, MRSc, is a distinguished professional in quality and regulatory compliance, with extensive expertise in cGXP adherence within the Life Sciences sector. At Healthcare Innovation Catalysts, she has successfully led the development and execution of comprehensive regulatory strategies, managing complex FDA submissions such as 510(k) Premarket Notifications, Investigational Device Exemptions (IDEs), and Device Classification Requests (513(g)) for cutting-edge medical devices and software as a medical device (SaMD) solutions. Throughout her career, Ms. Valdez Nava has conducted and overseen compliance audits across FDA and EU jurisdictions, implemented robust quality management systems, and built programs to ensure inspection readiness and operational excellence. She has also designed and implemented comprehensive internal and external audit programs and navigated evolving regulatory landscapes to minimize risk and accelerate market entry. With a Master of Science in Regulatory Science from Johns Hopkins University, complemented by multiple professional certifications, including Regulatory Affairs Certified (RAC) for Medical Devices, Ms. Valdez Nava is committed to advancing healthcare innovation while ensuring strict compliance with regulatory standards.